Physician

Stuart Martin Goldsmith, M.D.

According to 2025 Medicare claims, Stuart Goldsmith, M.D. (NPI: 1336201813) practices dermatology in the Albany, GA market, with the plurality of this provider's patient population coming from Dougherty, GA. This provider's primary affiliated billing organization is SOUTHWEST GEORGIA DERMATOLOGY, P.C. (NPI: 1508076969; TIN: 582002843) and primary practice location at 31707-0205.

Goldsmith's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 976 traditional Medicare patients, billed 4,747 HCPCS/CPT codes, and received $146,135 in Medicare payments. The top billing code was 11102 (Biopsy of related skin growth, first growth). Part D data shows 1,280 prescription claims across 510 beneficiaries totaling $1,050,661 in drug costs, led by Cosentyx Sensoready (2 Pens) (Secukinumab). Open Payments data shows 2 records totaling $154. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $212,628 to $146,135. In contrast, Part D prescription costs have moved sharply higher in recent years, from $132,614 to $1,050,661. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,489	7,574	$212,628
2016	1,495	8,532	$231,507
2017	1,464	8,093	$219,117
2018	1,404	8,336	$231,396
2019	1,403	7,674	$217,505
2020	1,080	5,163	$147,255
2021	1,086	5,564	$190,153
2022	1,015	5,326	$178,979
2023	979	4,896	$164,446
2024	976	4,747	$146,135

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	418	956	$132,614
2016	453	1,031	$134,409
2017	432	920	$139,260
2018	476	958	$215,219
2019	474	1,082	$447,714
2020	427	970	$490,822
2021	400	976	$452,625
2022	458	1,102	$613,640
2023	441	1,243	$844,929
2024	510	1,280	$1,050,661

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
11102	Biopsy of related skin growth, first growth	271	341	$54
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	772	1,125	$53
99212	Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more	200	233	$33
17000	Destruction of precancer skin growth, 1 growth	459	697	$32
17003	Destruction of precancer skin growth, 2-14 growths	326	1,663	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Cosentyx Sensoready (2 Pens)	Secukinumab	31	868	$217,003
Humira Pen	Adalimumab	18	728	$172,418
Humira	Adalimumab	17	476	$114,624
Taltz Autoinjector	Ixekizumab	14	392	$94,639
Dupixent Syringe	Dupilumab	20	644	$88,978

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$154	Regeneron Healthcare Solutions, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Stuart Martin Goldsmith, M.D.?

Tedicare shows public-source Medicare data for Stuart Martin Goldsmith, M.D. (NPI 1336201813), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Stuart Martin Goldsmith, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Stuart Martin Goldsmith, M.D.?

Stuart Martin Goldsmith, M.D. is linked to SOUTHWEST GEORGIA DERMATOLOGY, P.C. (billing NPI 1508076969) in the available physician profile data.

Does Stuart Martin Goldsmith, M.D. have Open Payments data?

Stuart Martin Goldsmith, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.